Skip to content

Generate Biomedicines, Inc. GENB Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

MYR Group logo
MYR GroupMYRG
$12.75M+4.6%
SSR Mining logo
SSR MiningSSRM
$2.21M+21.4%
Piper Sandler logo
Piper SandlerPIPR
$97.22M-3.4%
Repligen logo
RepligenRGEN
$21.07M+39.0%
LKQ logo
LKQLKQ
$254M+3.7%
AppFolio logo
AppFolioAPPF
$5M+14.4%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's operating lease liabilities (current)?
Generate Biomedicines, Inc. (GENB) reported operating lease liabilities (current) of $10.38M in Q1 2026.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.